Part 2: Alan Auerbach President & CEO Puma Biotech - YouTube
Shareholders to Recover $55 Million in Rare Jury Verdict
PUMA BIOTECHNOLOGY, INC. FORM 8-K/A - Shareholder.com
Neratinib Improves PFS in HER2+ Metastatic Breast Cancer
Alan H. Auerbach - Los Angeles Business Journal
Barry Simon vs Alan Auerbach | Comparably
Robbins Geller Rudman & Dowd LLP Announces Plaintiff's Verdict in Securities Class Action Trial Against Puma Biotechnology, Inc. and Its Ceo, Alan H. Auerbach
Alan Auerbach - Berkeley Law
Puma Biotech victory in neratinib litigation
Alan H. Auerbach - Chief Executive Officer & President @ Puma Biotechnology - Crunchbase Person Profile
Puma Biotechnology Executive Salaries | Comparably
Is Puma off the cancer M&A list? With Nerlyx marketing deal, some investors think so | Fierce Pharma
Puma Biotechnology Announces $10 Million Private Placement | Business Wire
Puma Biotechnology, Inc. - Puma Biotechnology Presents Results from the Phase II SUMMIT Trial of Neratinib for ERBB2 (HER2) Mutant, HER2 Non-Amplified, Metastatic Breast Cancer at the 2019 San Antonio Breast Cancer
Puma Biotechnology CEO And Leadership: Executives and Demographics - Zippia
A Top Puma Bio Exec Resigns Ahead of FDA Panel, Analysts Defend With Conflicting Stories - TheStreet
Alan Auerbach email address & phone number | Puma Biotechnology, Inc Chief Executive Officer, President contact information - RocketReach
Alan H. Auerbach Net Worth (2023) | wallmine
Alan Auerbach
Alan AUERBACH | CEO | Puma Biotechnology, Inc, California | Corporate | Research profile
Alan Auerbach
Puma Biotechnology Inc. (NYSE: PBYI) shareholders vote against PPD founder Fred Eshelman - Triangle Business Journal
JP Morgan Healthcare, Day 3: Puma Biotechnology, Natera | Precision Oncology News
